Purpose

The purpose of the study is to determine if using SIS System for DBS planning results in less distance between the planned target location and the actual implanted lead location than DBS planning without SIS System.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Subject is diagnosed with Idiopathic Parkinson's Disease and is indicated for de novo DBS surgery with bilateral DBS leads implanted in the STN or GPi. - Subject is 18 years or older. - Subject must be able and willing to provide informed consent and comply with study follow-up schedule and procedures.

Exclusion Criteria

  • Subject is not a DBS surgical candidate due to untreated, clinically significant depression, current suicidal ideation, or dementia or any neuropsychological condition or finding that would contraindicate DBS surgery. - Subject had prior intracranial surgery or other implanted neurostimulators or drug delivery pumps. - Subject's life expectancy is less than one year. - Subject is Hoehn and Yahr stage 4-5 in the medication OFF condition. - Subject is pregnant or interested in becoming pregnant during the duration of the study. - Subject is currently enrolled in another clinical study utilizing investigational medications, devices, or treatment that would conflict with this protocol.

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
SIS Group Standard of care DBS surgery + use of (FDA-cleared) SIS System for preoperative target planning
  • Device: SIS System
    FDA-cleared software that enhances standard clinical images for the visualization of structures in the basal ganglia area of the brain which are commonly targeted for DBS lead placement.
Control Group Standard of care DBS surgery and preoperative target planning

Recruiting Locations

University of Arizona
Tucson, Arizona 85724
Contact:
Illiana Gomez
ilianagomez@arizona.edu

University of Arkansas for Medical Sciences
Little Rock, Arkansas 72205
Contact:
Allyson Cheathem
501-526-7906
AJCheathem@uams.edu

Hartford Hospital
Hartford, Connecticut 06106
Contact:
Cory Bosworth
cory.bosworth@hhchealth.org

University of Miami
Miami, Florida 33136
Contact:
Letitia Fisher
LFisher@med.miami.edu

University of South Florida
Tampa, Florida 33606
Contact:
Carlos Rodriguez-Cosme
crodriguezcosme@tgh.org

University of Iowa
Iowa City, Iowa 52242
Contact:
Lil Bergan
319-335-1692
elizabeth-bergan@uiowa.edu

Beth Israel Deaconess Medical Center
Boston, Massachusetts 02215
Contact:
Suzanne Krishfield
617-667-0605
skrishfi@bidmc.harvard.edu

Duke University
Durham, North Carolina 27705
Contact:
Leah Whitaker
leah.benson@duke.edu

Penn State University
Hershey, Pennsylvania 17033
Contact:
Amanda Snyder
asnyder9@pennstatehealth.psu.edu

Carilion Clinic
Roanoke, Virginia 24014
Contact:
Leila Zavar
lazavar@carilionclinic.org

More Details

NCT ID
NCT05774041
Status
Recruiting
Sponsor
Surgical Information Sciences Inc.

Study Contact

Lisa Ingham
612-242-2226
lisa.ingham@surgicalis.com

Detailed Description

This is a prospective, controlled, open-label, multicenter post-market trial to compare standard of care DBS surgery to standard of care plus visualization with the SIS System. The purpose of the study is to determine if using SIS System for DBS planning results in less distance between the planned target location and the actual implanted lead location than DBS planning without SIS System. Parkinson's Disease subjects indicated for DBS will undergo standard DBS surgery with preoperative planning for targeting of STN or GPi as indicated. Subjects will be followed through six months after initial DBS programming to collect clinical outcomes.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.